ID   Farage-Luc2
AC   CVCL_B6JL
DR   ATCC; CRL-2630-LUC2
DR   Wikidata; Q123031262
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-2630-LUC2).
CC   Doubling time: 33 hours (ATCC=CRL-2630-LUC2).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC   Transfected with: UniProtKB; P33967; B.cereus Bsr.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000027.
ST   Source(s): ATCC=CRL-2630-LUC2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 8,9
ST   TPOX: 9
ST   vWA: 14,15
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3302 ! Farage
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//